Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

34.340
+0.3401.00%
Volume:5.89M
Turnover:202.62M
Market Cap:208.24B
PE:31.55
High:34.680
Open:34.000
Low:33.420
Close:34.000
52wk High:43.939
52wk Low:27.882
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:0.54
T/O Rate:0.10%
Dividend:0.43
Dividend Rate:1.26%
EPS(LYR):1.088
ROE:19.40%
ROA:9.08%
PB:4.71
PE(LYR):31.55
PS:11.19

Loading ...

HANSOH PHARMA Shares Surge on New Drug Application Acceptance

Stock News
·
Jun 05

Hansoh Pharma seeks shareholder approval for 2026 share option and award scheme

Reuters
·
Jun 04

Hansoh Pharma announces annual general meeting notice

Reuters
·
Jun 04

Hansoh Pharmaceutical's Weight-loss Injection Enters China Review

MT Newswires Live
·
Jun 04

BRIEF-Hansoh Pharmaceutical Says NDA For Olatorepatide Injection Accepted By China's NMPA

Reuters
·
Jun 04

HANSOH PHARMA's Obesity Drug Application Accepted by Chinese Regulator

Stock News
·
Jun 04

Hansoh Pharma says China regulator accepts NDA for olatorepatide weight management injection

Reuters
·
Jun 04

Hansoh Pharmaceutical - Nda for Olatorepatide Injection Accepted by Nmpa of China for Chronic Weight Management

THOMSON REUTERS
·
Jun 04

Hansoh Pharmaceutical Group Stock Sheds 2.3% in Hong Kong

Dow Jones
·
Jun 03

Hansoh Pharmaceutical Group Stock Sheds 7.1% in Hong Kong

Dow Jones
·
May 28

Innovative Drug Stocks Decline in Hong Kong Amid Rate Hike Expectations and ASCO Conference Focus

Stock News
·
May 28

Movement Alert|Hansoh Pharmaceutical Falls 6.04% in Regular Trading, Trading at 31.9 HKD

Market Focus
·
May 28

Hansoh Pharmaceutical Group’s Valuation After HS-10541 Clinical Trial Approval For KRAS G12C Tumors

Simply Wall St.
·
May 27

BUZZ-J&T Global Express leads gain in newcomers to Hang Seng Index

Reuters
·
May 26

Hang Seng Index Quarterly Review Boosts Industrial and Healthcare Sector Coverage; Six Stocks May Enter Southbound Trading

Stock News
·
May 25

Hang Seng Index Quarterly Review Results Announced: New Additions Include J&T Express, BeiGene, and CHALCO

Deep News
·
May 22

Hansoh Pharmaceutical Group Stock Falls 1.1% in Hong Kong

Dow Jones
·
May 22

Hansoh Pharma Clinches NMPA Breakthrough Designation for Fourth-Gen Cancer Tablet

MT Newswires Live
·
May 22

HANSOH PHARMA's Fourth-Generation EGFR Inhibitor HS-10504 Granted Breakthrough Therapy Designation for Lung Cancer

Stock News
·
May 21

Hansoh Pharma Receives NMPA Breakthrough-Therapy Designation for Fourth-Gen EGFR-TKI HS-10504

Bulletin Express
·
May 21